Afrza
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Website
www.afrezza.comRevenue
$11.2 MillionIndustry
About Afrza
Is Afrza your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Afrza launches new products
Congratulate Masked Content for being promoted to Masked Content at Afrza
Check if Afrza has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Afrza recently announced quarterly report
Check out if Afrza is spiking on competitors!
Funding: Get notified immidiatlly once Afrza has new funding data
Afrza, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Afrza had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Afrza
Compare insights from companies similar to Afrza, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Afrza is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Afrza is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Afrza.
Afrza Tech Stack
A closer look at the technologies used by Afrza
Afrza News & Media
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
MannKind Announces FDA Approval of Afrezza® the 1st & Only Inhaled Mealtime Insulin for Use in Children & Adolescents Aged 6 and Older Living with DiabetesMannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
MANNKIND TO SHOWCASE NEW DATA AT ADA 2026 ADVANCING UNDERSTANDING OF INHALED INSULIN (AFREZZA®) IN PEDIATRIC CARE, PREGNANCY AND USE WITH AID SYSTEMSMannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
MANNKIND TO PRESENT NEW DATA FROM PEDIATRIC AND ADULT STUDIES OF AFREZZA® AT ATTD 2026MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Afrza
Afrza is a company that operates in the Pharmaceuticals industry. It employs 5to9 people and has 10Mto25M of revenue.... Read More